483
Hybrid Pharma LLCFDA 483 - Hybrid Pharma LLC - November 09, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Hybrid Pharma LLC, an outsourcing facility in Deerfield Beach, FL, revealed significant deficiencies in aseptic processing, laboratory controls, and record-keeping. Observations included contaminated HEPA filters, inadequate media fill simulations, unvalidated test methods, and the compounding of drug substances on the Category 2 list. Many of these issues were repeat observations from previous inspections, indicating persistent non-compliance.
Open in Dashboard
ID · d260439c-a40b-448d-8aa6-2a6123db72c8